Professional Documents
Culture Documents
secondary care hospital in South Auckland, New Zealand. Intern Med J. 2015;45:160–169.
Mokdad AA, Lopez AD, Shahraz S, . Liver cirrhosis mortality in 187 countries between 1980 and 2010:
Chiang JL. (2014). Liver physiology: Metabolism and detoxification. Pathobiology of Human Disease,
pp. 1770-1782
Guengerich, F.P., Cheng, Q., 2011. Orphans in the human cytochrome P450 superfamily: approaches to
Moore, M.C., Coate, K.C., Winnick, J.J., An, Z., Cherrington, A.D., 2012. Regulation of hepatic glucose
Cohen, J.C., Horton, J.D., Hobbs, H.H., 2011. Human fatty liver disease: old questions and new insights.
G. Vernon, A. Baranova, Z.M. Younossi, Systematic review: the epidemiology and natural history of
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment. Pharmacol.
I.R. Wanless, J.S. Lentz, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis
K. Bambha,. Ethnicity and nonalcoholic fatty liver disease, Hepatology 55 (3) (2012) 769e780.
M. Ekstedt, ., Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology 44
Goldman, Lee. Cecil Textbook of Medicine -- 2-Volume Set, Text with Continually Updated Online
Iredale JP. "Cirrhosis: new research provides a basis for rational and targeted treatments". BMJ; 2001:
327: 143–147.
Sembulingam K, sembulingam P. Liver and Gallblader, chapter 40 In: essentials of medical physiology,
3rd edition, jaypee brothers medical publishers (p)ltd: new delhi;2004. page no.200-201
Chien-Jen Chen, Hwai-I. Yang, Jun Su, Chin-Lan Jen, San-Lin You, Sheng-Nan Lu, Guan-Tarn Huang,
Polson J, Lee WM."AASLD position paper: the management of acute liver failure". Hepatology.2005;
41: 1179–97.
Dawkins MJ. Carbon tetrachloride poisoning in the liver of the new born rat. J.path.bact.1963; 85:189.
Ambrose A.M, DeEds F, Rather L.J. further studies on toxicity of thioacetamide in rats. Proc. Soc. Exp.
Pandey A, Bigoniya P, Raj V, Patel K. Pharmacological screening of Coriandrum sativum Linn. for
de Vries J, de Jong J, Lock F, van Bree L,Mullink H, Veldhuizen R. Protection against paracetamol-
McCord, J.M. The evolution of free radicals and oxidative stress. Am. J. Med. 2000, 108, 652–659
Sanchez-Valle, V.; Chavez-Tapia, N.C.; Uribe, M.; Mendez-Sanchez, N. Role of oxidative stress and
molecular changes in liver fibrosis: A review. Curr. Med. Chem. 2012, 19, 4850–4860
Mallikarjuna, K.; Shanmugam, K.R.; Nishanth, K.; Wu, M.C.; Hou, C.W.; Kuo, C.H.; Reddy, K.S.
by exercise training in the liver of old rats. Alcohol 2010, 44, 523–529.
Tang, W.; Jiang, Y.F.; Ponnusamy, M.; Diallo, M. Role of Nrf2 in chronic liver disease. World J.
Klaassen, C.D.; Reisman, S.A. Nrf2 the rescue: Effects of the antioxidative/electrophilic response on the
Tang, W.; Jiang, Y.F.; Ponnusamy, M.; Diallo, M. Role of Nrf2 in chronic liver disease. World J.
Esrefoglu, M. Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis. Hepat.
Zhu, H.; Jia, Z.; Misra, H.; Li, Y.R. Oxidative stress and redox signaling mechanisms of alcoholic liver
disease: Updated experimental and clinical evidence. J. Dig. Dis. 2012, 13, 133–142.
Diehl, A.M. Recent events in alcoholic liver disease V. Effects of ethanol on liver regeneration. Am. J.
metabolism to cocaine-induced liver and kidney damage. Curr. Med. Chem. 2012, 19, 5601–560
Videla, L.A. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms.
Linares, V.; Alonso, V.; Albina, M.L.; Belles, M.; Sirvent, J.J.; Domingo, J.L.; Sanchez, D.J. Lipid
peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine.
Mladenovic, D.; Radosavljevic, T.; Ninkovic, M.; Vucevic, D.; Jesic-Vukicevic, R.; Todorovic, V. Liver
antioxidant capacity in the early phase of acute paracetamol-induced liver injury in mice. Food
Samarghandian, S.; Afshari, R.; Farkhondeh, T. Effect of long-term treatment of morphine on enzymes,
oxidative stress indices and antioxidant status in male rat liver. Int. J. Clin. Exp. Med. 2014, 7,
1449–1453.
Pieniazek, A.; Czepas, J.; Piasecka-Zelga, J.; Gwozdzinski, K.; Koceva-Chyla, A. Oxidative stress
induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel. Adv. Med. Sci.
Sha Li, Hor-Yue Tan, NingWang, Zhang-Jin Zhang, Lixing Lao, Chi-WoonWong and Yibin Feng.The
Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci. 2015, 16, 26087–
26124
Mahantesh S.P., Gangawane A.K. and Patil C.S. 2012. Free Radicals, Antioxidants, Diseases And
Phytomedicines In Human Health: Future Perspects. World Research Journal Of Medicinal &
Frazier, T.H.; Stocker, A.M.; Kershner, N.A.; Marsano, L.S.; McClain, C.J. Treatment of alcoholic liver
Diehl, A.M.; Chute, J. Underlying potential: Cellular and molecular determinants of adult liver repair. J.
Li, A.N.; Li, S.; Li, H.B.; Xu, D.P.; Xu, X.R.; Chen, F. Total phenolic contents and antioxidant capacities
Augustyniak, A.; Waszkiewicz, E.; Skrzydlewska, E. Preventive action of green tea from changes in the
liver antioxidant abilities of different aged rats intoxicated with ethanol. Nutrition 2005, 21, 925–
932.
Lirussi, F.; Azzalini, L.; Orando, S.; Orlando, R.; Angelico, F. Antioxidant supplements for non-
alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst. Rev. 2007, 24
Sattar, N.; Forrest, E.; Preiss, D. Non-alcoholic fatty liver disease. BMJ 2014, 349, 8.
Lee, J.H.; Friso, S.; Choi, S.W. Epigenetic mechanisms underlying the link between non-alcoholic fatty
Carter-Kent, C.; Zein, N.N.; Feldstein, A.E. Cytokines in the pathogenesis of fatty liver and disease
progression to steatohepatitis: Implications for treatment. Am. J. Gastroenterol. 2008, 103, 1036–
1042.
Evans, J.L.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Are oxidative stress-activated signaling
pathways mediators of insulin resistance and -cell dysfunction? Diabetes 2003, 52, 1–8.
Bogdanova, K.; Poczatkova, H.; Uherkova, L.; Riegrova, D.; Rypka, M.; Feher, J.; Marchesini, G.;
Vesely, J. Non-alcoholic fatty liver disease (NAFLD)—A novel common aspect of the metabolic
syndrome. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2006, 150, 101–104.
Ye, X.; Feng, Y.; Tong, Y.; Ng, K.M.; Tsao, S.; Lau, G.K.; Sze, C.; Zhang, Y.; Tang, J.; Shen, J.; .
Cheung, F.; Feng, Y.B.; Wang, N.; Yuen, M.F.; Tong, Y.; Wong, V.T. Effectiveness of Chinese herbal
O'Brien RD. (1976) Acetylcholinesterase and its inhibition. In: Insecticide Biochemistry and Physiology.
Abou-Donia MB. (1981) Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol
Toxicol 21:511-548
Hussain MA, Matin MA. (1986 a) Cerebral glycolysis and glycogenolysis in diazinon treated animals.
Fenichel GM, Dettbarn WD, Newmann TM. (1974) An experimental myopathy secondary to excessive
Steeno OP, Pangkahila A. (1984) Occupational influences on male fertility and sexuality. Andrologia 16:
5-22.
Georgian L. (1975) The comparative cytogenetic effects of aldrin and phosphamidon. Mat Res 31: 103-
108.
Venkat JA, Shanti S, Davis K, Nayak M. Plimmer JR, Pfeil R, Nair PP. (1995) Relative genotoxic
activities of pesticides evaluated by a modified SOS microplate assay. Environ Mol Mutagen 25:
67-76
Tsatsakis AM, Aguridakis P, Michalodimitrakis MN, Tsakalov AK, Alegakis AK, Koumantakls E,
Troulakis G. (1996) Experiences with acute organophosphate poisonings in Crete. Vet Hum
Lee IP, Dixon RL. (1978) Factors influencing reproduction and genetic toxic effects on male gonads.
USEPA: United States Environmental Protection Agency (1994) Integrated Risk Information System
(IRIS) on Dichlorvos. Environmental Criteria and Assessment Office, Office of Health and
FAO/UNEP. (1992). Dichlorvos draft decision guidance document prepared for FAO/UNEP joint group
Harlin, K.S. and Dellinger, J.A. (1993). Retina, brain and blood cholinesterase levels in cats treated with
Olinski R, Walter Z, Wiaderkiewicz R, Lukasova E, Palecek E. (1980) Changes in DNA properties due
to treatment witli tlie pesticides malathion and DDVP. Radiat Environ Biophys 18: 65-72.
both in vivo and in vitro. Hua Hsi Ko Ta Hsiteh Hstieh Pao 24: 82-86.
Herrera E. and Barbas C. (2001).Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57
(2): 43 – 56.
Wells W., Xu D., Yang Y., Rocque P. (1990). "Mammalian thioltransferase (glutaredoxin) and protein
disulfide isomerase have dehydroascorbate reductase activity". J Biol Chem 265 (26): 15361 – 4.
Smirnoff N. (2001). "L-ascorbic acid biosynthesis". Vitam Horm 61: 241 – 66.
Dewick P.M. (1995). The Biosynthesis of Shikimate Metabolites, Natural Product Reports 12:579-607
Rice-Evans C.A.; Miller N.J. and Paganga, G. (1997). Structure –antioxidant activity relationships of
Cai, Q.; Rahn R.O. and Zhang R. (1997). Oncogens and their roles in carcinogenesis. Cancer Lett. 119:
99-107.
Philipson JD., Natural products as basis for new drugs, Trends in pharmacology scienccs, 1980; 1:81-85.
Lin, C.C., Chen Y.L., Lin, J.M., Ujiie, T.: Am J Chin Med, 25(2): 153–161(1997).
Shinde, V., Dhalwal, K., Mahadik, K.R.: Pharmacologyonline News Letter 2: 1-11 (2007).
Ahmed, S.M., Swamy Bm, V., Gopkumar, P., R Dhanapal, R., Chandrashekara, V.M.: IJPT, 4: 22-28
(2005)
Ta-Chen, L and Feng L.H.: J. Chin. Chem. Soc., 46: 2-12( 1991).
Yun-Lian, L.,Yueh-Hsiung, K., Ming-Shi, S., Chien-Chih, C., Jun- Chih,O: J. Chin Chem Soc, 47: 253-
256(2000).
Oliveira, , J.T.A., Vasconcelos, I.M., Bezerra, L.C.N.M., Silveira, S.B., Monteiro, A.C.O., Moreira
D.S. Mohale, A.P. Dewani , A.V. Chandewar , C.D.Khadse, A.S. Tripathi, S.S. Agrawal. 2009. Brief